Investigation in Progress — No Complaint Filed Yet
BG&G is actively investigating potential securities fraud claims against Xylem Inc.. If a complaint is filed, this page will be updated. Investors are encouraged to contact us now to preserve their rights.
Why Is Xylem Inc. (XYL) Under Investigation?
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of shareholders of Xylem Inc. (NYSE: XYL).
On October 27, 2026, Xylem Inc. reported its third-quarter 2026 financial results, including revenue of approximately $2.20 billion, compared to estimates of roughly $2.28 billion, and adjusted earnings per share of $1.44, compared to analyst estimates of $1.45–$1.46. The Company also reduced its full-year 2026 revenue outlook by approximately $700 million to $8.95 billion and lowered its adjusted earnings per share guidance to $5.40–$5.45 from $5.55–$5.70. The Company had raised its earnings guidance the previous quarter and reaffirmed it on August 18, 2026, when announcing the appointment of a new Chief Financial Officer.
Following this news, Xylem’s stock price dropped on October 27, 2026.
What Potential Securities Violations Is BG&G Investigating?
- Whether Xylem Inc. and certain of its officers made false or misleading statements regarding the Company's financial condition and business prospects.
- Whether Xylem Inc. failed to disclose material adverse information that would have been significant to a reasonable investor.
- Whether the Company's earnings guidance was supported by a reasonable factual basis at the time it was made.
What Should Xylem Inc. (XYL) Investors Do?
How Is Xylem Inc. (NYSE: XYL) Stock Trading Today?
How Does BG&G Help Investors in Securities Fraud Investigations?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
We handle cases on a contingency fee basis — we advance all litigation costs on your behalf. There is no fee unless we are successful.
“Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace.”